価格表

在庫・価格 : 2025年10月25日 13時51分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Human HGF Affinity Purified Polyclonal Ab
データシート※最新のデータシートでない場合があります
AF-294-SP RSDアールアンドディー システムズ
R&D Systems, Inc.
25 μg ¥28,000 1個 追加

在庫・価格 : 2025年10月25日 13時51分 現在

Anti-Human HGF Affinity Purified Polyclonal Ab

  • 商品コード:AF-294-SP
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥28,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Qiu SQ et al. High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer. Breast Cancer Res 2020 03;22(1):30
Qiu SQ et al
2020/01/01
Species: Human, Applications: IHC PubMed
2 Vogel S et al. Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET. J. Biol. Chem. 2014 Ap
Vogel S et al
2014/01/01
Species: Human, Applications: Neutralization PubMed
3 Imura Y et al. Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcoma. Mol. Cancer 2014;13:185
Imura Y et al
2014/01/01
Species: Human, Applications: IHC-P PubMed
4 Nagashima K et al. Priming with FGF2 stimulates human dental pulp cells to promote axonal regeneration and locomotor function recovery after spinal cord injury. Sci Rep 2017 Oct;7(1):13500
Nagashima K et al
2017/01/01
Species: Human, Applications: ICC PubMed
5 Zhou Y et al. Spontaneous genomic alterations in a chimeric model of colorectal cancer enable metastasis and guide effective combinatorial therapy. PLoS ONE 2014;9(8):e105886
Zhou Y et al
2014/01/01
PubMed
6 Chiba S et al. Functional mononucleotide repeat polymorphism in the promoter region of HGF is associated with risk and malignant aggressiveness of bladder cancer. Int. J. Oncol. 2014 Mar;44(3):678-84
Chiba S et al
2014/01/01
Species: Human, Applications: IHC-P PubMed
7 Vermeulen L et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 2010 May;12(5):468-76
Vermeulen L et al
2010/01/01
Species: Human, Applications: ICC PubMed
8 Zoratti GL et al. Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling. Nat Commun 2015;6:6776
Zoratti GL et al
2015/01/01
Species: Human, Applications: Western Blot PubMed
9 Chang HK et al. Coronary stents with inducible VEGF/HGF-secreting UCB-MSCs reduced restenosis and increased re-endothelialization in a swine model. Exp. Mol. Med. 2018 09;50(9):114
Chang HK et al
2018/01/01
Species: Human, Applications: Western Blot PubMed
10 Matsushima A et al. Hepatocyte growth factor in polymorphonuclear leukocytes is increased in patients with systemic inflammatory response syndrome. J Trauma 2004 Feb;56(2):259-64
Matsushima A et al
2004/01/01
Species: Human, Applications: Western Blot PubMed
11 Suga H et al. IFATS collection: Fibroblast growth factor-2-by adipose-derived stromal cells inhibits postinjury fibrogenesis through a c-Jun N-terminal kinase-dependent mechanism. Stem Cells 2009 Jan;27(1):238-49
Suga H et al
2009/01/01
Species: Mouse, Applications: Neutralization PubMed
12 Zoratti GL et al. Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancer. Oncotarget 2016 Sep;7(36):58162-58173
Zoratti GL et al
2016/01/01
Species: Human, Applications: Western Blot PubMed
13 Nicoleau C et al. Endogenous hepatocyte growth factor is a niche signal for subventricular zone neural stem cell amplification and self-renewal. Stem Cells 2009 Feb;27(2):408-19
Nicoleau C et al
2009/01/01
Species: Canine, Applications: Neutralization PubMed
14 Giacobini P et al. Hepatocyte growth factor acts as a motogen and guidance signal for gonadotropin hormone-releasing hormone-1 neuronal migration. J. Neurosci. 2007 Jan;27(2):431-45
Giacobini P et al
2007/01/01
Species: Mouse, Applications: Western Blot PubMed
15 Tamberg T et al. Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors. J. Biol. Chem. 2019 01;294(1):314-326
Tamberg T et al
2019/01/01
Species: Human, Applications: Western Blot PubMed
16 Buchstein N et al. Alternative proteolytic processing of hepatocyte growth factor during wound repair. Am. J. Pathol. 2009 Jun;174(6):2116-28
Buchstein N et al
2009/01/01
Species: Human, Applications: Western Blot PubMed
17 Skibinski G et al. Bronchial epithelial cell growth regulation in fibroblast cocultures: the role of hepatocyte growth factor. Am. J. Physiol. Lung Cell Mol. Physiol. 2007 Jul;293(1):L69-76
Skibinski G et al
2007/01/01
Species: Human, Applications: Neutralization PubMed
18 Felix AS et al. Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients. Br. J. Cancer 2012 Jun;106(12):2004-9
Felix AS et al
2012/01/01
Species: Human, Applications: IHC-P PubMed
19 Ramani VC et al. Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activity. J. Biol. Chem. 2011 Feb;286(8):6490-9
Ramani VC et al
2011/01/01
Species: Human, Applications: Immunoprecipitation PubMed
20 Szabo R et al. c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase. Oncogene 2011 Apr;30(17):2003-16
Szabo R et al
2011/01/01
Species: Human, Applications: Western Blot PubMed
21 Kawai A et al. Establishment and characterization of a biphasic synovial sarcoma cell line, SYO-1. Cancer Lett. 2004 Feb;204(1):105-13
Kawai A et al
2004/01/01
Species: Human, Applications: ICC PubMed
  • No.: 1
  • 文献情報:
    Qiu SQ et al. High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer. Breast Cancer Res 2020 03;22(1):30
    Qiu SQ et al
    2020/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Vogel S et al. Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET. J. Biol. Chem. 2014 Ap
    Vogel S et al
    2014/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Imura Y et al. Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcoma. Mol. Cancer 2014;13:185
    Imura Y et al
    2014/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Nagashima K et al. Priming with FGF2 stimulates human dental pulp cells to promote axonal regeneration and locomotor function recovery after spinal cord injury. Sci Rep 2017 Oct;7(1):13500
    Nagashima K et al
    2017/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Zhou Y et al. Spontaneous genomic alterations in a chimeric model of colorectal cancer enable metastasis and guide effective combinatorial therapy. PLoS ONE 2014;9(8):e105886
    Zhou Y et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Chiba S et al. Functional mononucleotide repeat polymorphism in the promoter region of HGF is associated with risk and malignant aggressiveness of bladder cancer. Int. J. Oncol. 2014 Mar;44(3):678-84
    Chiba S et al
    2014/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Vermeulen L et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 2010 May;12(5):468-76
    Vermeulen L et al
    2010/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Zoratti GL et al. Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling. Nat Commun 2015;6:6776
    Zoratti GL et al
    2015/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Chang HK et al. Coronary stents with inducible VEGF/HGF-secreting UCB-MSCs reduced restenosis and increased re-endothelialization in a swine model. Exp. Mol. Med. 2018 09;50(9):114
    Chang HK et al
    2018/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Matsushima A et al. Hepatocyte growth factor in polymorphonuclear leukocytes is increased in patients with systemic inflammatory response syndrome. J Trauma 2004 Feb;56(2):259-64
    Matsushima A et al
    2004/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Suga H et al. IFATS collection: Fibroblast growth factor-2-by adipose-derived stromal cells inhibits postinjury fibrogenesis through a c-Jun N-terminal kinase-dependent mechanism. Stem Cells 2009 Jan;27(1):238-49
    Suga H et al
    2009/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Zoratti GL et al. Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancer. Oncotarget 2016 Sep;7(36):58162-58173
    Zoratti GL et al
    2016/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Nicoleau C et al. Endogenous hepatocyte growth factor is a niche signal for subventricular zone neural stem cell amplification and self-renewal. Stem Cells 2009 Feb;27(2):408-19
    Nicoleau C et al
    2009/01/01
  • 備考:
    Species: Canine, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Giacobini P et al. Hepatocyte growth factor acts as a motogen and guidance signal for gonadotropin hormone-releasing hormone-1 neuronal migration. J. Neurosci. 2007 Jan;27(2):431-45
    Giacobini P et al
    2007/01/01
  • 備考:
    Species: Mouse, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Tamberg T et al. Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors. J. Biol. Chem. 2019 01;294(1):314-326
    Tamberg T et al
    2019/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Buchstein N et al. Alternative proteolytic processing of hepatocyte growth factor during wound repair. Am. J. Pathol. 2009 Jun;174(6):2116-28
    Buchstein N et al
    2009/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Skibinski G et al. Bronchial epithelial cell growth regulation in fibroblast cocultures: the role of hepatocyte growth factor. Am. J. Physiol. Lung Cell Mol. Physiol. 2007 Jul;293(1):L69-76
    Skibinski G et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Felix AS et al. Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients. Br. J. Cancer 2012 Jun;106(12):2004-9
    Felix AS et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Ramani VC et al. Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activity. J. Biol. Chem. 2011 Feb;286(8):6490-9
    Ramani VC et al
    2011/01/01
  • 備考:
    Species: Human, Applications: Immunoprecipitation
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Szabo R et al. c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase. Oncogene 2011 Apr;30(17):2003-16
    Szabo R et al
    2011/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Kawai A et al. Establishment and characterization of a biphasic synovial sarcoma cell line, SYO-1. Cancer Lett. 2004 Feb;204(1):105-13
    Kawai A et al
    2004/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed